Science Explorer Interactive view Map
Company · Tokyo · Japan

Taisho Pharmaceutical (Japan)

In research, Taisho Pharmaceutical (Japan) stands highest in Life Sciences (#4,171 of 14,347 worldwide), Medicine (#9,773 of 17,978 worldwide) and Neuroscience (#1,494 of 2,675 worldwide), over all time.

taisho.co.jp/enROR OpenAlex
World rank, all time
#9,890
of 42,892
Rank in Japan
#380
of 2,112
Research works
1.1k
▲ 20% vs 2013–17
Citations
27k
24.9 per fractional work
Top-10% rate
23.3%
record average 16.5%
Open access
41%
world 28%

What is Taisho Pharmaceutical (Japan) known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
Life SciencesDomain #4,171 of 14,347 10.2%517
MedicineField #9,773 of 17,978 14.5%331
NeuroscienceField #1,494 of 2,675 18.1%130
Health SciencesDomain #12,664 of 20,462 14.3%353
Physical SciencesDomain #14,085 of 21,541 7.4%188
Biochemistry, Genetics and Molecular BiologyField #5,489 of 7,814 7.0%286
Molecular BiologySubfield #4,726 of 4,961 6.0%186
ChemistryField #3,262 of 3,369 5.9%131

Each strip is that field’s whole ranked pool, with the notch where Taisho Pharmaceutical (Japan) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.16× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.89× its world share, 9 worksBiochemistry, Geneti…Immunology and Microbiology: 3.87× its world share, 2 worksImmunology and Micro…Neuroscience: 2.91× its world share, 2 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 6.82× its world share, 1 worksPharmacology, Toxico…Chemistry: 1.78× its world share, 1 worksChemistryEngineering: 0.14× its world share, 1 worksEngineeringEnvironmental Science: 0.24× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.08× its world share, 0 worksMaterials ScienceMathematics: 0.22× its world share, 0 worksMathematicsHealth Professions: 0.07× its world share, 0 worksHealth ProfessionsMedicine: 2.98× its world share, 25 worksMedicineNursing: 1.06× its world share, 0 worksNursingPsychology: 0.93× its world share, 1 worksPsychology1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 6.8×. Every wedge is a field page.

Who are the top researchers at Taisho Pharmaceutical (Japan)?

Ranked on the composite score, Takashi Adachi, Yoshiaki Watanabe and Shigeyuki Chaki lead among researchers whose main affiliation is Taisho Pharmaceutical (Japan).

  1. 1 Takashi Adachi Japan · #393,600 worldwide 162 citations · 73 works
  2. 2 Yoshiaki Watanabe Japan · #410,154 worldwide 72 citations · 50 works
  3. 3 Shigeyuki Chaki Japan · #443,068 worldwide 117 citations · 32 works
  4. 4 Kazuhiko Sagara Japan · #658,360 worldwide 34 citations · 16 works
  5. 5 Yutaka Nakanishi Japan · #950,605 worldwide 13 citations · 21 works
  6. 6 Iwao Arai Japan · #989,583 worldwide 47 citations · 17 works
  7. 7 Shohei Higuchi Japan · #1,006,507 worldwide 47 citations · 20 works
  8. 8 Kazunori Hanada Japan · #1,027,720 worldwide 34 citations · 15 works
  9. 9 Takanobu Sakurai Japan · #1,146,197 worldwide 27 citations · 19 works
  10. 10 Shigeru Okuyama Japan · #1,185,008 worldwide 45 citations · 48 works
All ranked researchers at Taisho Pharmaceutical (Japan)

Which keywords describe research at Taisho Pharmaceutical (Japan)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Inflammation, Angiogenesis, Metabolism, Autoantibodies, Cancer Therapy, Resistance Training, Cell Signaling and Reactive Oxygen Species.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Inflammation6▲ 6.7×20 topics
  2. Angiogenesis4▲ 29×5 topics
  3. Metabolism3▲ 15×8 topics
  4. Autoantibodies3▲ 30×3 topics
  5. Cancer Therapy3▲ 12×6 topics
  6. Epidemiology3▲ 1.62×11 topics
  7. Cell Signaling2▲ 36×4 topics
  8. Resistance Training2▲ 61×2 topics
  9. Reactive Oxygen Species2▲ 12×3 topics
  10. Cancer Progression2▲ 26×2 topics
  11. Tumor Microenvironment2▲ 11×3 topics
  12. Immune Function2▲ 58×2 topics
  13. Cytokines2▲ 15×4 topics
  14. Exercise-Induced Oxidative Stress2▲ 152×1 topic
  15. Fibrosis2▲ 23×3 topics
  16. Muscle-Derived Interleukin-62▲ 152×1 topic
  17. Oxidative Stress2▲ 2.6×8 topics
  18. Matrix Metalloproteinases2▲ 29×3 topics
  19. Toll-like Receptors2▲ 36×3 topics
  20. Extracellular Matrix2▲ 22×2 topics
  21. Metabolic Syndrome2▲ 4.7×5 topics
  22. Cytochrome P4502▲ 106×2 topics
  23. Extracellular Matrix Remodeling2▲ 241×1 topic
  24. Fibroblast Activation Protein2▲ 80×1 topic
  25. Immunosuppression2▲ 39×1 topic
  26. Performance Analysis2▲ 16×1 topic
  27. Synaptic Plasticity2▲ 16×3 topics
  28. Tissue Inhibitors of Metalloproteinases2▲ 241×1 topic
  29. Training Load2▲ 55×1 topic
  30. Treatment1▲ 2.7×4 topics
  31. Circadian Rhythms1▲ 30×2 topics
  32. Hypertension1▲ 11×3 topics
  33. Pulmonary Involvement1▲ 75×1 topic
  34. Systemic Sclerosis1▲ 75×1 topic
  35. Transcriptional Regulation1▲ 18×3 topics
  36. Cardiovascular Function1▲ 68×2 topics
  37. Exercise1▲ 21×2 topics
  38. Rheumatoid Arthritis1▲ 27×2 topics
  39. Nutrition1▲ 5.3×2 topics
  40. Therapeutic Targets1▲ 15×3 topics

Which research topics does Taisho Pharmaceutical (Japan) publish most on?

By volume in 2022–2025: Exercise and Physiological Responses, Peptidase Inhibition and Analysis, Sports Performance and Training and Protease and Inhibitor Mechanisms.

Exercise and Physiologic…2Exercise and Physiological Responses: 2 fractional worksPeptidase Inhibition and…2Peptidase Inhibition and Analysis: 2 fractional worksSports Performance and T…2Sports Performance and Training: 2 fractional worksProtease and Inhibitor M…2Protease and Inhibitor Mechanisms: 2 fractional worksSystemic Sclerosis and Related Diseases: 1 fractional worksSystemic Lupus Erythematosus Research: 1 fractional worksMuscle metabolism and nu…1Muscle metabolism and nutrition: 1 fractional worksRheumatoid Arthritis Res…1Rheumatoid Arthritis Research and Therapies: 1 fractional worksEicosanoids and Hyperten…1Eicosanoids and Hypertension Pharmacology: 1 fractional worksMonoclonal and Polyclona…1Monoclonal and Polyclonal Antibodies Research: 1 fractional works
RehabilitationOncologyOrthopedics and Sports MedicineCancer Research5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Exercise and Physiological Responses Rehabilitation 2 works
  2. 2 Peptidase Inhibition and Analysis Oncology 2 works
  3. 3 Sports Performance and Training Orthopedics and Sports Medicine 2 works
  4. 4 Protease and Inhibitor Mechanisms Cancer Research 2 works
  5. 5 Systemic Sclerosis and Related Diseases Pathology and Forensic Medicine 1 works
  6. 6 Systemic Lupus Erythematosus Research Rheumatology 1 works
  7. 7 Muscle metabolism and nutrition Cell Biology 1 works
  8. 8 Rheumatoid Arthritis Research and Therapies Rheumatology 1 works
  9. 9 Eicosanoids and Hypertension Pharmacology Biochemistry 1 works
  10. 10 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available41.0%not open59.0%

World: 28% of research is openly available.

with international co-authors5.9%domestic only94.1%

World: 19% is written across borders.

How has Taisho Pharmaceutical (Japan)'s research output changed?

Output in 2018–2022 was 20% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.